Press releases in 2002

19. 12. 2002 |
DEAR SHAREHOLDERS,
29. 11. 2002 |
Ljubljana, 29 November 2002 – The Slovenian pharmaceutical company Lek d.d. received another final approval from the US regulatory authorities (Food and Drug Administration) to immediately start the distribution and ...
29. 11. 2002 |
Ljubljana, 29 November 2002 – The new strategic alliance of Lek Pharmaceuticals d.d. represents yet another milestone in the company’s development. By maintaining its identity and through the synergy of ...
26. 11. 2002 |
Ljubljana, 26 November 2002 – The Slovenian pharmaceutical company Lek d.d. received final approval from the US regulatory authorities (Food and Drug Administration) to immediately start the distribution and sales ...
26. 11. 2002 |
In accordance with Article 50 of the Takeovers Act, with Article 66 of the Securities Market Act, and with the Rules of the Ljubljana Stock Exchange d.d., Ljubljana, Lek Pharmaceuticals ...
22. 11. 2002 |
RESULT OF THE BID ISSUED BY COMPANY SERVIPHARM AG, BASEL, SWITZERLAND FOR PURCHASE OF THE SHARES OF COMPANY LEK PHARMACEUTICALS D.D., VEROVŠKOVA 57, 1526 LJUBLJANA, BASED ON LICENSE BY SECURITIES ...
21. 11. 2002 |
Deal positions Novartis Generics as a leader in the extended European market including the Eastern and South Eastern Europe and CIS region. Basel, 21 November 2002 – Novartis announced today ...
18. 11. 2002 |
The pharmaceutical company Lek, Verovskova 57, 1526 Ljubljana, in accord with the provisions of article 66 of the ZTVP and the Rules of the Ljubljana Stock Exchange, Ljubljana, informs the ...
12. 11. 2002 |
Ljubljana, 12 November 2002 – Lek Pharmaceuticals d.d. announces that at the 17th General Meeting held today its shareholders adopted the proposed resolutions that had been rejected at the 16th ...
30. 10. 2002 |
In accordance with the provisions of Article 66 of the Securities Market Act and with the Rules of the Ljubljana Stock Exchange, Lek Pharmaceuticals d.d., Verovškova 57, Ljubljana hereby announces
30. 10. 2002 |
26% sales growth of Lek d.d. and of Lek Group in the first 9 months of 2002
22. 10. 2002 |
In accordance with the provisions of Article 66 of the Securities Market Act and with the Rules of the Ljubljana Stock Exchange, Lek Pharmaceuticals d.d. hereby announces
21. 10. 2002 |
In accordance with the provisions of Article 66 of the Securities Market Act and with the Rules of the Ljubljana Stock Exchange d.d., Lek Pharmaceuticals d.d., Ljubljana, hereby announces
21. 10. 2002 |
On the basis of the request made by the minority of Lek shareholders (Pension Fund Management d.d., Ljubljana, Slovenian Restitution Fund d.d., Ljubljana, NFD 1 Investment Fund p.l.c., represented by ...
18. 10. 2002 |
Announcement in accordance with the provisions of Article 66 of the Securities Market Act-1 and Rules of the Ljubljana Stock Exchange, d.d., Ljubljana
5. 10. 2002 |
Based on the provisions of Article 25 of the Takeover Act (Official Gazette of the Republic of Slovenia No. 47/97 and 56/99) the Board of Management of Lek Pharmaceuticals d.d., ...
1. 10. 2002 |
Ljubljana, 1 October 2002 – Lek Pharmaceuticals d.d., Verovškova 57, Ljubljana, hereby announces that its subsidiary Lek Zagreb d.o.o., Maksimirska 120, Zagreb, Croatia, has received a temporary injunction from the ...
30. 9. 2002 |
In accordance with the provisions of the Securities Market Act-1 and the Rules of the Ljubljana Stock Exchange d.d., Ljubljana Lek Pharmaceuticals d.d., Verovškova 57, Ljubljana, announces that,
27. 9. 2002 |
Lek Pharmaceuticals d. d. announces that the resolutions proposed at today’s Extraordinary General Meeting of shareholders have not been approved. In the announcement regarding its intention to make an offer ...
29. 8. 2002 |
Novartis intends, subject to certain conditions, to make an offer to acquire all of the capital stock of Lek for 95,000 Slovenian Tolars (SIT) per share, a premium of more ...
28. 8. 2002 |
In accordance with the Rules of the Ljubljana Stock Exchange , d.d., Ljubljana, and with Article 66 of the Securities Market Act – 1, Lek Pharmaceutical Company d. d., Verovškova ...
14. 8. 2002 |
Lendava, August 13 – The Lendava Waste Water Treatment Plant (WWTP) officially commenced operation in August 2001, and on July 17 it signed a concession agreement with the Lendava municipality ...
5. 8. 2002 |
Ljubljana, 5 August – This year’s semiannual sales of the Lek Group amounted to SIT 46 billion, a 23% increase compared with the same period last year. Lek’s future plans ...
15. 7. 2002 |
Ljubljana – The US Food and Drug Administration has completed a comprehensive inspection of several of the Company’s facilities during the period of June 17 to July 4, 2002. The ...
8. 7. 2002 |
Ljubljana, Targu Mures, 8 July 2002 – The Slovenian pharmaceutical company Lek d.d. laid the foundation stone of the new production plant in Romania in the presence of the President ...
2. 7. 2002 |
Ljubljana, July 1 – The Slovenian pharmaceutical company Lek announces that it has received final approval from U.S. regulatory authorities to immediately start the distribution and sales of the ACE ...
28. 6. 2002 |
Ljubljana, 24 June; The 15th Annual General Meeting took place today at the premises of Lek d. d. The shareholders discussed and supported the proposal on the use of profit, ...
26. 6. 2002 |
Prevalje, 25 June – Upon Slovenia’s National Day and the Prevalje municipal holiday, Metod Dragonja, President of Lek Board of Management, delivered the keys of the new fire engine to ...
6. 6. 2002 |
Ljubljana, June 4 – Recently, the media reporting on the events in the Stock Exchange and in the economy have frequently mentioned the company Lek d. d. with regard to ...
6. 5. 2002 |
Ljubljana, May 6, 2002 – Today, with the president of the Republic of Slovenia, Milan Kučan, and prominent representatives of the Slovenian scientific and business communities in attendance, the Slovenian ...
24. 4. 2002 |
Lendava, April 23 – The pharmaceutical company Lek d. d., hosted many visitors from the Lendava neighborhood. By holding an open house today at its facility in Lendava, Lek sought ...
8. 4. 2002 |
On Monday, 8 April 2002, the business daily Finance granted for the third year running awards to the company ranking highest on the Stock Exchange. The rating procedure included all ...
27. 3. 2002 |
Ljubljana, March 27- Today, the Slovenian pharmaceutical company Lek officially opened a completely renovated production plant in Ljubljana for the manufacture of sterile products. With the opening of this facility ...
27. 3. 2002 |
Ljubljana, March 27 – The Slovenian pharmaceutical company Lek exceeded expectations and projected goals for the year 2001. Accordingly, the Executive Board, meeting on March 21, 2002, proposed to pay ...
28. 1. 2002 |
Ljubljana, January 31 – The Slovenian pharmaceutical company Lek announces that it has received approval from US regulatory authorities to immediately market the dopamine receptor agonist bromocriptine mesylate tablets in ...
28. 1. 2002 |
Ljubljana, January 28 – The Slovenian pharmaceutical company Lek exceeded its sales objectives in 2001. In that period, Lek sales reached SIT 68 billion, exceeding projected goals by 8 percent, ...
23. 1. 2002 |
Starting January 1, 2002, Lek Kozmetika began operations as a completely independent daughter company of the pharmaceutical firm Lek. The Cosmetics Unit used to be an integrated part of Lek ...
14. 1. 2002 |
It is people that build today and tomorrow’s Lek. We are pleased to announce the following promotions to Managing Directors: